...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>EFSA Journal >Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus helveticus CNCM I‐1722, Bifidobacterium longum subsp. infantis CNCM I‐3424, Bifidobacterium bifidum CNCM I 3426 and fructo oligosaccharides from sucrose and contribution to immune defence against pathogens (ID 3016, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【24h】

Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus helveticus CNCM I‐1722, Bifidobacterium longum subsp. infantis CNCM I‐3424, Bifidobacterium bifidum CNCM I 3426 and fructo oligosaccharides from sucrose and contribution to immune defence against pathogens (ID 3016, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译：关于证实与瑞士乳杆菌CNCM I-1722和长双歧杆菌亚种的组合有关的健康声明的科学意见。根据1924/2006号法规（EC）第13（1）条，从蔗糖中提取婴儿CNCN I-1324，双歧杆菌CNCM I 3426和果糖寡糖，以及对病原体的免疫防御作用（ID 3016，进一步评估）

获取原文
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on a health claim pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to a combination of Lactobacillus helveticus CNCM I‐1722, Bifidobacterium longum subsp. infantis CNCM I‐3424, Bifidobacterium bifidum CNCM I‐3426 and fructo‐oligosaccharides from sucrose and immune defence against pathogens. The food constituent that is the subject of the health claim, a combination of L. helveticus CNCM I‐1722, B. longum subsp. infantis CNCM I‐3424, B. bifidum CNCM I‐3426 and fructo‐oligosaccharides from sucrose, is sufficiently characterised. The claimed effect, contribution to immune defence against pathogens, is a beneficial physiological effect. The proposed target population is the general population. No human intervention studies were provided from which conclusions could be drawn for the scientific substantiation of the claim. On the basis of the data provided, the Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of L. helveticus CNCM I‐1722, B. longum subsp. infantis CNCM I‐3424, B. bifidum CNCM I‐3426 and fructo‐oligosaccharides from sucrose and contribution to immune defence against pathogens.
机译：应欧洲委员会的要求，要求营养产品，营养和过敏问题专家组（NDA）在进一步评估的框架内，根据1924/2006号法规（EC）第13条就健康声明提供科学意见与瑞士乳杆菌CNCM I-1722，长双歧杆菌亚种的组合有关。婴儿的CNCM I-3424，双歧双歧杆菌CNCM I-3426和蔗糖中的果糖低聚糖以及对病原体的免疫防御。健康声明所涉及的食物成分是瑞士乳杆菌CNCM I-1722，长双歧杆菌亚种。充分表征了婴儿的CNCM I-3424，双歧双歧杆菌CNCM I-3426和蔗糖中的果糖低聚糖。要求保护的作用，有助于抵抗病原体的免疫防御，是有益的生理作用。建议的目标人群是普通人群。没有提供任何人为干预研究，可以从中得出结论以对索赔进行科学证实。根据提供的数据，小组得出结论，食用瑞士乳杆菌CNCM I-1722，长双歧杆菌亚种的组合之间尚未建立因果关系。婴儿的CNCM I-3324，双歧双歧杆菌CNCM I-3426和蔗糖中的果糖低聚糖以及对病原体的免疫防御作用都有所贡献。

著录项

  • 来源
    《EFSA Journal》 |2012年第8期|共15页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号